Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
SGD Pharma
SGD Pharma
Activities:
Packaging
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
SGD Pharma successfully trials hydrogen burners at its Saint-Quentin-Lamotte
SGD Pharma’s decarbonisation roadmap aims to reduce CO2 emissions from 2020 by 35% in 2030 and by 65% in 2040
Packaging
SGD Pharma awarded 2024 gold EcoVadis rating
SGD Pharma’s sustainability rating of 77 puts the business in the 98th percentile for manufacturers of glass and glass products
Drug Delivery
SGD Pharma introduces its new range of Type I tubular vials
SGD partner with Corning to announce its new range of type I injectable vials in tubular glass with an added external low-friction coating
Packaging
SGD Pharma expands capacity for siliconised glass vials with new production lines
SGD Pharma announces the opening of a new siliconisation operation at its state-of-the-art Saint-Quentin Lamotte (SQLM) plant
Media
SGD Pharma announces the appointment of Fabio Invernizzi, General Manager West Business Unit
The BU West includes SGD Pharma’s commercial activities for MEA, North and South America and our manufacturing footprint in Europe
Packaging
SGD Pharma defines 2024 growth strategy as it strives for market leadership
SGD Pharma announces its goal to become the global market leader in primary pharmaceutical glass packaging
Sustainability
SGD Pharma commits to near-term science-based targets initiative as part of sustainability drive
SGD Pharma announces its commitment to company wide emissions reductions as part of its decarbonisation strategy by joining the Science Based Targets initiative (SBTi)
Subscribe now